These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 34763479)
1. Anorectal melanoma and gene analysis of personalized adjuvant therapy: a case report. Cai X; Zhu X Ann Palliat Med; 2021 Oct; 10(10):11216-11220. PubMed ID: 34763479 [TBL] [Abstract][Full Text] [Related]
2. Anorectal Mucosal Melanoma in the Era of Immune Checkpoint Inhibition: Should We Change Our Surgical Management Paradigm? Adileh M; Yuval JB; Huang S; Shoushtari AN; Quezada-Diaz F; Pappou EP; Weiser MR; Garcia-Aguilar J; Smith JJ; Paty PB; Nash GM Dis Colon Rectum; 2021 May; 64(5):555-562. PubMed ID: 33939387 [TBL] [Abstract][Full Text] [Related]
4. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients. Schaefer T; Satzger I; Gutzmer R Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717 [TBL] [Abstract][Full Text] [Related]
9. Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors. Olbryt M; Rajczykowski M; Widłak W Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517213 [TBL] [Abstract][Full Text] [Related]
10. Unexpected post-operative diagnosis of primary rectal melanoma. A case report. Erdas E; Calò PG; Licheri S; Pomata M G Chir; 2014; 35(5-6):137-9. PubMed ID: 24979106 [TBL] [Abstract][Full Text] [Related]
11. Anorectal malignant melanoma: treatment with surgery or radiation therapy, or both. Moozar KL; Wong CS; Couture J Can J Surg; 2003 Oct; 46(5):345-9. PubMed ID: 14577706 [TBL] [Abstract][Full Text] [Related]
12. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma. Saito R; Sawada Y; Nakamura M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410 [TBL] [Abstract][Full Text] [Related]
13. Anorectal melanoma with a KIT-activating mutation, which is a target for tyrosine kinase inhibitor. Itoh M; Goto A; Wakasugi H; Yoshida Y; Matsunaga Y; Fujii K; Suzuki K; Yonezawa K; Abe T; Arimura Y; Shinomura Y Int J Clin Oncol; 2011 Aug; 16(4):428-34. PubMed ID: 21069551 [TBL] [Abstract][Full Text] [Related]
14. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Helmke BM; Mollenhauer J; Herold-Mende C; Benner A; Thome M; Gassler N; Wahl W; Lyer S; Poustka A; Otto HF; Deichmann M Gastroenterology; 2004 Dec; 127(6):1815-20. PubMed ID: 15578519 [TBL] [Abstract][Full Text] [Related]
15. PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors. Kakavand H; Rawson RV; Pupo GM; Yang JYH; Menzies AM; Carlino MS; Kefford RF; Howle JR; Saw RPM; Thompson JF; Wilmott JS; Long GV; Scolyer RA; Rizos H Clin Cancer Res; 2017 Oct; 23(20):6054-6061. PubMed ID: 28724663 [No Abstract] [Full Text] [Related]
16. [Diagnosis and treatment of anorectal malignant melanoma--a report of 22 cases with literature review]. Zhong J; Zhou JN; Xu FP; Shang JQ Ai Zheng; 2006 May; 25(5):619-24. PubMed ID: 16687086 [TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. Vilain RE; Menzies AM; Wilmott JS; Kakavand H; Madore J; Guminski A; Liniker E; Kong BY; Cooper AJ; Howle JR; Saw RPM; Jakrot V; Lo S; Thompson JF; Carlino MS; Kefford RF; Long GV; Scolyer RA Clin Cancer Res; 2017 Sep; 23(17):5024-5033. PubMed ID: 28512174 [No Abstract] [Full Text] [Related]
18. Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab. Brüggemann C; Kirchberger MC; Goldinger SM; Weide B; Konrad A; Erdmann M; Schadendorf D; Croner RS; Krähenbühl L; Kähler KC; Hafner C; Leisgang W; Kiesewetter F; Dummer R; Schuler G; Stürzl M; Heinzerling L J Cancer Res Clin Oncol; 2017 Oct; 143(10):1977-1984. PubMed ID: 28616701 [TBL] [Abstract][Full Text] [Related]